Form 4: Robert Azelby, Terns Pharmaceuticals Director, Acquires 90,000 Stock Options

Director Robert Azelby reports acquisition of 90,000 stock options in Terns Pharmaceuticals, vesting over three years.

Summary

• Robert Azelby, a director of Terns Pharmaceuticals, acquired 90,000 stock options on February 20, 2025.
• The options have an exercise price of $4.13.
• The options vest over three years, starting February 20, 2025, with one-third vesting on the first anniversary and the remainder vesting monthly thereafter.
• The expiration date for the options is February 19, 2035.
• Following the transaction, Azelby directly owns 90,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard transaction (stock option grant) which indicates confidence from the director in the company's future, but doesn't contain any groundbreaking news.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule suggests a long-term commitment from the director.

Industry Context

This is a standard SEC Form 4 filing, reflecting a common practice of granting stock options to company directors as part of their compensation package. It's typical for biotech companies to use stock options to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in the pharmaceutical industry, aligning their interests with those of shareholders.
• The vesting schedule of three years is fairly standard for such grants, encouraging long-term commitment.
• Comparable companies like Madrigal Pharmaceuticals and Viking Therapeutics also utilize stock options as part of their executive compensation packages.

Key Dates

Keywords

stock options, director, Terns Pharmaceuticals, Form 4, beneficial ownership, Azelby, TERN